Yingsheng Biology
Jinan
About Yingsheng Biology
Yingsheng Biotechnology Co., Ltd. (referred to as Yingsheng Bio) was established in 2009, and is committed to the application of molecular diagnostic techniques such as maternal and child health, neonatal genetic diseases, metabolic diseases, birth defects and other human genetics, and national eugenics engineering. Yingsheng's product line includes 45 innovative genetic metabolic disease screening reagents, 14 vitamins determination reagents, mass spectrometer automatic intelligent processing platform, and ultra-high performance liquid chromatography tandem mass spectrometry detection system. level.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $14.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2022)
- Website: ivdys.com
- Phone: +86 0531-55561690
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Canonical: https://fsome.com/organization/yingsheng-biology-12026 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.